A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis

NCT01536795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

FED

Sponsor class

Conditions

Old World Cutaneous Leishmaniasis

Interventions

DRUG: WR279,396 with Tegaderm Dressing
DRUG: WR 279,396 with Gauze and Tape Dressing

Sponsor

U.S. Army Medical Research and Development Command